|
1. Ludvigsson JF, Leffler DA, Bai JC, et al. The Oslo definitions for coeliac disease and related terms. Gut. 2013; 62:43-52. doi:10.1136/gutjnl-2011-301346. 2. Reilly NR, Aguilar K, Hassid BG, et al. Celiac disease in normal-weight and overweight children: clinical features and growth outcomes following a gluten-free diet. J Pediatr Gastroenterol Nutr. 2011;53: 528-31. doi: 10.1097/MPG.0b013e3182276d5e. 3. Valletta E, Fornaro M, Cipolli M, Conte S, Bissolo F, Danchielli C. Celiac disease and obesity: need for nutritional follow-up after diagnosis. Eur J Clin Nutr. 2010; 64:1371-2. doi:10.1038/ejcn.2010.161. 4. Norsa L, Shamir R, Zevit N, et al. cardiovascular disease risk factor profiles in children with celiac disease on gluten-free diets. World J Gastroenterol. 2013; 19:5658-64. doi:10.3748/wjg. v19.i34.5658. 5. Reilly NR, Lebwohl B, Hultcrantz R, Green PH, Ludvigsson JF. Increased risk of non-alcoholic fatty liver disease after diagnosis of celiac disease. J Hepatol. 2015; 62:1405-11. doi: 10.1016/j.jhep.2015.01.013. 6. Tovoli F, Negrini G, Farì R, et al. Increased risk of nonalcoholic fatty liver disease in patients with coeliac disease on a gluten-free diet: beyond traditional metabolic factors. Aliment Pharmacol Ther. 2018; 48:538-46. doi:10.1111/apt.14910. 7. Reilly NR, Lebwohl B, Hultcrantz R, Green PH, Ludvigsson JF. Increased risk of non-alcoholic fatty liver disease after diagnosis of celiac disease. J Hepatol. 2015; 62:1405-11. doi: 10.1016/j.jhep.2015.01.013. 8. Adibi A, Kelishadi R, Beihaghi A, Salehi H, Talaei M. Sonographic fatty liver in overweight and obese children, a cross-sectional study in Isfahan. Endokrynol Pol. 2009; 60:14-19. 9. Namakin K, Hosseini M, Zardast M, Mohammadifard M. Prevalence of Non-Alcoholic Fatty Liver Disease (NAFLD) and its Clinical Characteristics in Overweight and Obese Children in the South East of Iran, 2017. Hepat Mon. 2018; 18: e83525. doi: 10.5812/hepatmon.83525. 10. Hassanipour S, Amini-Salehi E, Joukar F, Khosousi MJ, Pourtaghi F, Ansar MM, et al. The Prevalence of Non-Alcoholic Fatty Liver Disease in Iranian Children and Adult Population: A Systematic Review and Meta-Analysis. Iran J Public Health. 2023; 52:1600-12. doi: 10.18502/ijph. v52i8.13399. 11. Tabaeian AP, Behzadifar M, Rezapour A, Azari S, Behzadifar M. Prevalence of non-alcoholic fatty liver disease among Iranians aged 6 to 18 years: a systematic review and meta-analysis. Yafte. 2023; 25:59-70. doi: 10.32592/Yafteh.2023.25.1.6. 12. Hill ID, Dirks MH, Liptak GS, et al. Guideline for the diagnosis and treatment of celiac disease in children: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr. 2005; 40:1-19. doi:10.1097/00005176-200501000-00001. 13. Zhang X, Heredia NI, Balakrishnan M, Thrift AP. Prevalence and factors associated with NAFLD detected by vibration controlled transient elastography among US adults: Results from NHANES 2017-2018. PLoS One. 2021;16: e0252164. doi: 10.1371/journal.pone.0252164. 14. Riazi K, Azhari H, Charette JH, et al. The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2022; 7:851-61. doi:10.1016/S2468-1253(22)00165-0. 15. Younossi ZM, Golabi P, Paik JM, Henry A, Van Dongen C, Henry L. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology. 2023; 77:1335-47. doi:10.1097/HEP.0000000000000004. 16. Younossi ZM, Stepanova M, Afendy M, et al. Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008. Clin Gastroenterol Hepatol. 2011; 9:524-e60. doi: 10.1016/j.cgh.2011.03.020. 17. Le MH, Le DM, Baez TC, et al. Global incidence of non-alcoholic fatty liver disease: A systematic review and meta-analysis of 63 studies and 1,201,807 persons. J Hepatol. 2023; 79:287-95. doi: 10.1016/j.jhep.2023.03.040. 18. Chegeni M, Nili S, Darabi M, et al. Prevalence of non-alcoholic fatty liver and its related factors in Iran: Systematic review and meta-analysis. J Educ Health Promot. 2023; 12:356. doi: 10.4103/jehp.jehp_1056_22. 19. Adibi A, Kelishadi R, Beihaghi A, Salehi H, Talaei M. Sonographic fatty liver in overweight and obese children, a cross-sectional study in Isfahan. Endokrynol Pol. 2009; 60:14-19. 20. Raiteri A, Granito A, Faggiano C, et al. Hepatic Steatosis in Patients with Celiac Disease: The Role of Packaged Gluten-Free Foods. Nutrients. 2022; 14:2942. doi:10.3390/nu14142942. 21. Tovoli F, Negrini G, Farì R, et al. Increased risk of nonalcoholic fatty liver disease in patients with coeliac disease on a gluten-free diet: beyond traditional metabolic factors. Aliment Pharmacol Ther 2018;48(5):538-546. doi:10.1111/apt.14910. 22. Babio N, Alcázar M, Castillejo G, et al. Patients with Celiac Disease Reported Higher Consumption of Added Sugar and Total Fat Than Healthy Individuals. J Pediatr Gastroenterol Nutr. 2017; 64:63-9. doi:10.1097/MPG.0000000000001251. 23. Brandi G, De Lorenzo S, Candela M, et al. Microbiota, NASH, HCC and the potential role of probiotics. Carcinogenesis. 2017; 38:231-40. doi:10.1093/carcin/bgx007.
|
